Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hopf

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantationD Seehofer, N Rayes, T Berg, et al.
Transplantation|June 3, 2000
Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary reportD Seehofer, N Rayes, T Berg, et al.
Transplantation Proceedings|November 20, 1997
Association between hepatitis and rejection: upregulation of cytokines and extracellular matrix parametersA R Mueller, K P Platz, T Berg, et al.
Zeitschrift Fur Gastroenterologie|August 1, 1994
[Long-term follow-up of chronic hepatitis C after treatment with recombinant interferon alpha-2a]U Hopf, S Küther, V König, et al.
Transplantation|August 13, 1998
Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantationT Berg, U Hopf, W O Bechstein, et al.
Klinische Wochenschrift|June 15, 1976
[Histocompatibility-(HLA) antigens in patients with HBsAg positive and negative hepatitis and healthy carriers of HBsAg and anti-HBs. (author's transl)]J Freudenberg, K H Meyer zum Büschefelde, W Arnold, et al.
British Medical Journal|January 22, 1977
Liver-cell-membrane autoantibody specific for inflammatory liver diseasesU Tage-Jensen, W Arnold, O Dietrichson, et al.
Transplantation|September 27, 1996
GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantationT Berg, U Naumann, T Fukumoto, et al.
Vox Sanguinis|May 22, 1998
Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated bloodH G Heuft, T Berg, E Schreier, et al.
Hepato-Gastroenterology|December 1, 1990
Glycoproteins of rat liver plasma membranes: their hepatocellular, intestinal and renal expression in rat, rabbit and humanU Hopf, R Stemerowicz, B Möller, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantationD Seehofer, N Rayes, T Berg, et al.
Transplantation|June 3, 2000
Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary reportD Seehofer, N Rayes, T Berg, et al.
Transplantation Proceedings|November 20, 1997
Association between hepatitis and rejection: upregulation of cytokines and extracellular matrix parametersA R Mueller, K P Platz, T Berg, et al.
Zeitschrift Fur Gastroenterologie|August 1, 1994
[Long-term follow-up of chronic hepatitis C after treatment with recombinant interferon alpha-2a]U Hopf, S Küther, V König, et al.
Transplantation|August 13, 1998
Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantationT Berg, U Hopf, W O Bechstein, et al.
Klinische Wochenschrift|June 15, 1976
[Histocompatibility-(HLA) antigens in patients with HBsAg positive and negative hepatitis and healthy carriers of HBsAg and anti-HBs. (author's transl)]J Freudenberg, K H Meyer zum Büschefelde, W Arnold, et al.
British Medical Journal|January 22, 1977
Liver-cell-membrane autoantibody specific for inflammatory liver diseasesU Tage-Jensen, W Arnold, O Dietrichson, et al.
Transplantation|September 27, 1996
GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantationT Berg, U Naumann, T Fukumoto, et al.
Vox Sanguinis|May 22, 1998
Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated bloodH G Heuft, T Berg, E Schreier, et al.
Hepato-Gastroenterology|December 1, 1990
Glycoproteins of rat liver plasma membranes: their hepatocellular, intestinal and renal expression in rat, rabbit and humanU Hopf, R Stemerowicz, B Möller, et al.
Pageof 18